Company & Sponsor Intelligence

Central Hospital, Nancy, France

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials7

Recruiting1

Completed3

Countries1

Therapeutic footprint

adhdalzheimersepilepsyparkinsons

Indexed studies

NCT06116084Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine
alzheimers · FranceNA

NCT06960811Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness
epilepsy · FranceCOMPLETED

NCT04275895Cognitive and Postural Activities of Prematurely Born Children
adhd · FranceNA

NCT05339438Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients
epilepsy · FranceNA

NCT04933513Development and Validation of a Scale Measuring Preoperative Expectations in Parkinson's Disease
parkinsons · FranceCOMPLETED

NCT02311829Evaluation of a Telephone Follow-up Procedure on the Quality of Life in Psychogenic Non-epileptic Seizures
epilepsy · FranceNA

NCT03753035Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children
epilepsy · FranceUNKNOWN

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →